Clinical Trial Update: The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression [Phase 3]

View source ↗

Summary

Phase 3 trial assessing quetiapine extended-release (Seroquel XR) as an adjunctive treatment for cognition, mood, and anxiety in SSRI-resistant unipolar depress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: University of British Columbia | Conditions: Unipolar Depression | Phase 3 | Status: COMPLETED